2 active not recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
| Phase 2 | 2 | Active not recruiting 2 |
Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Radiation Therapy, Temozolomide Oral Product - Glioblastoma | Phase 1 / Phase 2 | Active not recruiting | John Flickinger | 2 | 2021-12-14 | 2025-06-18 |
| Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome Autologous CD34+ cells transduced with WASP lentiviral vector - Wiskott-Aldrich Syndrome | Phase 1 / Phase 2 | Active not recruiting | Genethon | 10 | 2014-09-01 | 2021-06-03 |
Glioblastoma (1) · Wiskott-Aldrich Syndrome (1)
Cytopenia (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Leukocyte Disorders (2) · Leukopenia (2) · Astrocytoma (1) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Glioma (1) · Hemorrhagic Disorders (1)
Radiotherapy (1)
Genethon (1) · John Flickinger (1)
France (1) · United Kingdom (1) · United States (1)